相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Con- trolling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Xia Sheng et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular Carcinoma
Won-Mook Choi et al.
HEPATOLOGY COMMUNICATIONS (2020)
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Diana Llopiz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
被撤回的出版物: Brazilein induces apoptosis and G1/G0 phase cell cycle arrest by up-regulation of miR-133a in human vestibular schwannoma cells (Retracted article. See vol. 127, 2022)
Zhongyan Mou et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Long noncoding RNA AURKAPS1 potentiates malignant hepatocellular carcinoma progression by regulating miR-142, miR-155 and miR-182
Jianhua Li et al.
SCIENTIFIC REPORTS (2019)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases
Emina Halilbasic et al.
DIGESTIVE DISEASES (2017)
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis
Martina Sombetzki et al.
JOURNAL OF HEPATOLOGY (2015)
Differential Regulation of EGFR-MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer
Sara M. Centuori et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines
Dominique Brossard et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways
Yang Xu et al.
PLOS ONE (2014)
Crosstalk between apoptosis, necrosis and autophagy
Vassiliki Nikoletopoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
NCX-1000, a Nitric Oxide-Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study
Annalisa Berzigotti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Marcelo Zaldini Hernandes et al.
CURRENT DRUG TARGETS (2010)
Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines
Dominique Brossard et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Primary Biliary Cirrhosis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation
In. H. Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: Roles of Ras, p38, and CCAAT/enhancer-binding protein
Sharad Khare et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice
P Fickert et al.
GASTROENTEROLOGY (2006)
Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-κB-dependent process in human cervical carcinoma cells
E Im et al.
CANCER LETTERS (2005)
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
DS Alberts et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver
S Fiorucci et al.
JOURNAL OF HEPATOLOGY (2003)
Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells
EO Im et al.
CANCER LETTERS (2001)
分享论文
